These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 33745456

  • 1. Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation.
    Zhao L, Li S, Zhang C, Tian J, Lu A, Bai R, An J, Greiser A, Huang J, Ma X.
    J Cardiovasc Magn Reson; 2021 Mar 22; 23(1):30. PubMed ID: 33745456
    [Abstract] [Full Text] [Related]

  • 2. Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation.
    Begg GA, Swoboda PP, Karim R, Oesterlein T, Rhode K, Holden AV, Greenwood JP, Shantsila E, Lip GYH, Plein S, Tayebjee MH.
    J Cardiovasc Magn Reson; 2020 Feb 10; 22(1):13. PubMed ID: 32036784
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction: correlation of global longitudinal strain with invasive diastolic functional indices.
    Ito H, Ishida M, Makino W, Goto Y, Ichikawa Y, Kitagawa K, Omori T, Dohi K, Ito M, Sakuma H.
    J Cardiovasc Magn Reson; 2020 Jun 04; 22(1):42. PubMed ID: 32498688
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive assessment of left atrial and ventricular remodeling in paroxysmal atrial fibrillation by the cardiovascular magnetic resonance myocardial extracellular volume fraction and feature tracking strain.
    Yamada A, Hashimoto N, Fujito H, Hatta T, Saito Y, Otsuka N, Wakamatsu Y, Arai M, Watanabe R, Kurokawa S, Kitano D, Nagashima K, Yoda S, Okumura Y.
    Sci Rep; 2021 May 25; 11(1):10941. PubMed ID: 34035345
    [Abstract] [Full Text] [Related]

  • 5. Reverse left ventricular structural remodeling after catheter ablation of atrial fibrillation in patients with preserved left ventricular function: Insights from cardiovascular magnetic resonance native T1 mapping.
    Kowallick JT, Staab W, Schuster A, Backhaus SJ, Weber-Krüger M, Bauer L, Sohns C, Lotz J, Hasenfuß G, Lüthje L, Zabel M, Bergau L.
    Heart Rhythm; 2019 Mar 25; 16(3):424-432. PubMed ID: 30248459
    [Abstract] [Full Text] [Related]

  • 6. Late effects of pediatric hematopoietic stem cell transplantation on left ventricular function, aortic stiffness and myocardial tissue characteristics.
    Paiman EHM, Louwerens M, Bresters D, Westenberg JJM, Tao Q, van der Geest RJ, Lankester AC, Roest AAW, Lamb HJ.
    J Cardiovasc Magn Reson; 2019 Jan 17; 21(1):6. PubMed ID: 30651110
    [Abstract] [Full Text] [Related]

  • 7. Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.
    Habibi M, Lima JA, Khurram IM, Zimmerman SL, Zipunnikov V, Fukumoto K, Spragg D, Ashikaga H, Rickard J, Marine JE, Calkins H, Nazarian S.
    Circ Cardiovasc Imaging; 2015 Feb 17; 8(2):e002769. PubMed ID: 25652181
    [Abstract] [Full Text] [Related]

  • 8. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction.
    Ling LH, Kistler PM, Ellims AH, Iles LM, Lee G, Hughes GL, Kalman JM, Kaye DM, Taylor AJ.
    J Am Coll Cardiol; 2012 Dec 11; 60(23):2402-8. PubMed ID: 23141493
    [Abstract] [Full Text] [Related]

  • 9. Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain.
    Cao Y, Zeng W, Cui Y, Kong X, Wang M, Yu J, Zhang S, Song J, Yan X, Greiser A, Shi H.
    Cardiovasc Diabetol; 2018 Jan 04; 17(1):7. PubMed ID: 29301529
    [Abstract] [Full Text] [Related]

  • 10. Left ventricular myocardial T1 mapping and strain analysis evaluate cardiac abnormality in hypothyroidism.
    Liu M, Liu W, Zhang P, An J, Wang G.
    Int J Cardiovasc Imaging; 2019 Mar 04; 35(3):507-515. PubMed ID: 30251176
    [Abstract] [Full Text] [Related]

  • 11. The worsening effect of paroxysmal atrial fibrillation on left ventricular function and deformation in type 2 diabetes mellitus patients: a 3.0 T cardiovascular magnetic resonance feature tracking study.
    Li XM, Yan WF, Shi K, Shi R, Jiang L, Gao Y, Min CY, Liu XJ, Guo YK, Yang ZG.
    Cardiovasc Diabetol; 2024 Mar 06; 23(1):90. PubMed ID: 38448890
    [Abstract] [Full Text] [Related]

  • 12. Early detection of left atrial and bi-ventricular myocardial strain abnormalities by MRI feature tracking in normotensive or hypertensive T2DM patients with preserved LV function.
    Shao G, Cao Y, Cui Y, Han X, Liu J, Li Y, Li N, Liu T, Yu J, Shi H.
    BMC Cardiovasc Disord; 2020 Apr 23; 20(1):196. PubMed ID: 32326882
    [Abstract] [Full Text] [Related]

  • 13. Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
    Kato S, Foppa M, Roujol S, Basha T, Berg S, Kissinger KV, Goddu B, Manning WJ, Nezafat R.
    Int J Cardiol; 2016 Jan 15; 203():848-54. PubMed ID: 26599750
    [Abstract] [Full Text] [Related]

  • 14. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M, Florian A, Dräger B, Young P, Yilmaz A.
    J Cardiovasc Magn Reson; 2016 Dec 07; 18(1):91. PubMed ID: 27931223
    [Abstract] [Full Text] [Related]

  • 15. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
    Yang Y, Yin G, Jiang Y, Song L, Zhao S, Lu M.
    J Cardiovasc Magn Reson; 2020 Jan 02; 22(1):1. PubMed ID: 31898543
    [Abstract] [Full Text] [Related]

  • 16. Identification of cardiovascular abnormalities by multiparametric magnetic resonance imaging in end-stage renal disease patients with preserved left ventricular ejection fraction.
    Lin L, Xie Q, Zheng M, Zhou X, Dekkers IA, Tao Q, Lamb HJ.
    Eur Radiol; 2021 Sep 02; 31(9):7098-7109. PubMed ID: 33629157
    [Abstract] [Full Text] [Related]

  • 17. Cardiac magnetic resonance T1 mapping for evaluating myocardial fibrosis in patients with type 2 diabetes mellitus: correlation with left ventricular longitudinal diastolic dysfunction.
    Liu X, Gao Y, Guo YK, Xia CC, Shi R, Jiang L, Shen MT, Xie LJ, Peng WL, Qian WL, Deng MY, Deng LL, Ren Y, Yang ZG.
    Eur Radiol; 2022 Nov 02; 32(11):7647-7656. PubMed ID: 35567605
    [Abstract] [Full Text] [Related]

  • 18. Novel imaging modalities in detection of cardiovascular involvement in ankylosing spondylitis.
    Ozkaramanli Gur D, Ozaltun DN, Guzel S, Sarifakioglu B, Akyuz A, Alpsoy S, Aycicek O, Baykiz D.
    Scand Cardiovasc J; 2018 Dec 02; 52(6):320-327. PubMed ID: 30462519
    [Abstract] [Full Text] [Related]

  • 19. T1-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T.
    Maforo NG, Magrath P, Moulin K, Shao J, Kim GH, Prosper A, Renella P, Wu HH, Halnon N, Ennis DB.
    J Cardiovasc Magn Reson; 2020 Dec 10; 22(1):85. PubMed ID: 33302967
    [Abstract] [Full Text] [Related]

  • 20. Left ventricular fibrosis in atrial fibrillation.
    Shantsila E, Shantsila A, Blann AD, Lip GY.
    Am J Cardiol; 2013 Apr 01; 111(7):996-1001. PubMed ID: 23332595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.